文献速递临床试验与 GCP真实世界研究与卫生经济

「旨在优化老年2型糖尿病患者降糖药物的减药方案——OMED2研究:随机对照试验」的统计分析计划

Statistical analysis plan of the study titled "A deprescribing programme aimed to optimize blood glucose-lowering medication in older people with type 2 diabetes mellitus - the OMED2 study: a randomized controlled trial".
PubMed 文献 · Trials · 2026-01-30

OMED2研究是一项随机混合方法研究,随访2年,比较在全科实践中实施减药方案与常规照护的效果。本统计分析计划详细描述拟用于分析糖尿病并发症总数、实施情况及成本效果的方法,主要采用泊松分布的广义线性混合模型,以减药方案为主要决定因素,并进行意向性分析与符合方案分析。

要点

  • OMED2研究比较全科实践中减药方案与常规照护,随访2年,主要结局为低治疗与过度治疗相关的糖尿病并发症总数。
  • 主要分析采用泊松分布的广义线性混合模型,以减药方案为主要决定因素,并纳入全科诊所随机效应以处理聚类。
  • 将计算糖尿病并发症发生率以校正随访时间差异,并进行意向性分析与符合方案分析。

核心结论

  • 本统计分析计划详细描述OMED2研究拟用于分析减药方案对糖尿病并发症总数、实施情况及成本效果的方法。

研究设计与样本

  • OMED2研究为随机混合方法研究,随访2年,比较全科实践中实施减药方案与常规照护(对照)。
  • 主要结局为低治疗与过度治疗相关的糖尿病并发症总数,从2年随访开始至随访结束期间发生。

主要发现

  • 主要分析采用泊松分布的广义线性混合模型,以减药方案为主要决定因素,检验干预组与对照组糖尿病并发症总数是否有差异。
  • 将计算糖尿病并发症发生数的事件率以校正随访时间可能存在的差异。
  • 模型纳入随机效应变量以允许全科诊所可能的聚类效应。
  • 将进行意向性分析(纳入所有符合减药条件的患者)及符合方案分析(排除干预组中未减药的患者)。
  • 统计分析计划还概述了研究减药方案实施情况及实施成本效果的方法。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The OMED2 (Optimization of Medication in Elderly with Diabetes) study addresses the effect and implementation of integrating a deprescribing programme (DPP) in general practice. The aim of the DPP is to reduce glucose-lowering medication (SU/insulin) in overtreated older patients. The protocol for this study has been published previously. This statistical analysis plan (SAP) contains a more elaborate outline of the (statistical) methods we plan to use for data analysis. METHODS: The OMED2 study is a randomized mixed-methods study with a 2-year follow-up period that compares the effect of the implementation of a DPP in general practice to regular care (control). In this SAP, we report on the (statistical) approaches that we plan to use to address the study objectives. The main objective of the OMED2 study is to examine the effect of the implementation of the DPP on diabetes complications, whereby the total number of diabetes complications related to undertreatment and overtreatment will be summed. Generalized linear mixed models with a Poisson distribution and the DPP as the main determinant will be used to test whether the total number of diabetes complications occurring from the start of the 2-year follow-up until the end of follow-up differs between intervention and control. The incident rate of the number of diabetes complications will be calculated to correct for possible differences in follow-up duration. The model will also include a random effect variable to allow for possible clustering effects by general practice. We will perform intention-to-treat analyses, which include all patients eligible for deprescribing, as well as per protocol analyses, which omit patients who were not deprescribed in the intervention arm. Additionally, approaches to study the implementation of the DPP and the cost-effectiveness of the implementation are outlined in the SAP. TRIAL REGISTRATION: ISRCTN Registry ISRCTN50008265. Registered on 1 November 2024.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Andriessen C, Harms PP, Blom MT, et al. Statistical analysis plan of the study titled "A deprescribing programme aimed to optimize blood glucose-lowering medication in older people with type 2 diabetes mellitus - the OMED2 study: a randomized controlled trial". Trials. 2026. PMID: 41612444. doi:10.1186/s13063-026-09442-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。